Recombinant human serum albumin (Mitsubishi Tanabe)

N/A

Report date: 2026/03/09 20:02:04

Base Information

Drug NameRecombinant human serum albumin (Mitsubishi Tanabe)
Drug Alias Name重组人血清AlbrecMedwayGB-1057RU-101 +[6
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionColloidal osmotic pressure modulators
TargetsNot applicable
Therapy Area/IndicationsHypoalbuminemiaXerophthalmia
Global Approved IndicationsHypoalbuminemia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2007/10/19
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMitsubishi Tanabe Pharma
China Registration ClassN/A

Develop Information

Active CompaniesMitsubishi Tanabe Pharma
Inactive CompaniesR-Tech Ueno Ltd
Active IndicationsHypoalbuminemia
Inactive IndicationsXerophthalmia

Other Information

ATC CodeB05AA01
Related LinksN/A